The Allurion balloon — originally called the Elipse balloon — is an intragastric balloon you swallow as a capsule, with no endoscopy, sedation, or anesthesia needed. Once it's confirmed in the stomach by X-ray, it's filled with about 550 mL of liquid. It stays in place for roughly four months to help you feel full and eat less, then empties on its own and passes naturally in the stool — no removal procedure required (Silva et al., Obesity Surgery, 2024; Jirapinyo & Thompson, Digestive Diseases and Sciences, 2022).

The Allurion balloon is the only gastric balloon that needs no endoscopy or anesthesia for placement or removal — you swallow it, and it passes on its own at about four months (Vantanasiri et al., Obesity Surgery, 2020). Other balloons (such as Orbera or Spatz) require an endoscopy to place and remove. Compared with a surgical sleeve gastrectomy, the balloon is non-surgical, temporary, and lower-risk, but produces less weight loss and is a shorter-term tool rather than a permanent change (Jirapinyo & Thompson, 2022).

To an extent, yes. Beyond the gene variants you inherit, animal studies show diet- and chemical-induced epigenetic marks can be passed to offspring, and human famine records suggest metabolic effects can echo across generations. The human evidence is associational and debated, while the strongest proof comes from animal models — but the mechanism (inheritance of chemical tags rather than DNA changes) is well established.

Diet clearly influences the epigenome. Nutrients that supply methyl groups (folate, B12, choline) and fiber fermented into short-chain fatty acids by gut bacteria both directly affect how genes are switched on or off. Diets low in these protective components and high in obesogenic exposures are associated with less favorable methylation patterns, though research distinguishing specific food types is still developing.

No. Inherited risk — genetic and epigenetic — loads the odds but does not fix the outcome. Many epigenetic marks are responsive to diet, exercise, sleep, and weight loss, meaning environment continues to shape gene activity throughout life. The "memory" effect makes change harder, not impossible.

Partly. Calorie reduction, exercise, and bariatric surgery measurably shift methylation toward healthier patterns. However, fat tissue retains an epigenetic memory of prior obesity that can persist for years and contributes to weight regain, so reversal is incomplete rather than total.

Most patients lose about 10–13% of their total body weight by the end of the treatment period — roughly 2–3 times what diet and exercise achieve alone (Elmaleh-Sachs et al., JAMA, 2023; Silva et al., Obesity Surgery, 2024). The adjustable balloon can reach about 15–16% total body weight loss, and the swallowable procedureless balloon averages about 12.5% by ~4 months. Because the balloon is temporary, some weight is typically regained afterward, so lasting results depend on continuing a structured diet, activity, and often medication after removal (McCarty & Thompson, Yamada's Textbook of Gastroenterology, 2022; Chan et al., Obesity Surgery, 2021).

‍

A gastric balloon is temporary, incisionless, and reversible — it is placed for about 4–6 months and then removed or passed naturally, with no permanent change to your anatomy — and is approved for a BMI of 30–40 (Elmaleh-Sachs et al., JAMA, 2023; Apovian et al., The Obesity Society, 2025). Bariatric surgery permanently changes the stomach (and sometimes the intestine), produces greater and more durable weight loss, and is used for higher BMIs. The balloon is best viewed as a lower-risk "jump-start" or a bridge to surgery, while surgery is the definitive option for more substantial, lasting weight loss (Laing et al., Digestive Diseases and Sciences, 2017).

‍

Lorem Ipsum

Yes — when combined with metabolic guidance and monitoring.

Not always — many patients succeed with medical treatment alone.